In conversation with WIRED

Professor Mark Kendall’s inventions have drawn attention from some of the world’s biggest names. Think the World Health Organization, the Bill & Melinda Gates Foundation and F1 Grand Prix winner Mark Webber.

Trials attract national attention

In recognition of the start of human trials for our hydration Microwearable sensor, WearOptimo has been the subject of a special 9 News feature.

No sweat as WearOptimo and Aspen Medical reach another milestone

Pictured (from left to right) - Professor Mark Kendall (Founder and CEO of WearOptimo), Professor Brian Schmidt (Vice-Chancellor of The Australian National University), and Glenn Keys (Aspen Medical Founder and Executive Chairman).

Healthtech innovator WearOptimo and leading healthcare provider Aspen Medical have reached another significant milestone in the commercialisation of ground-breaking microwearable hydration sensors.

Aspen Medical has shown its further confidence in WearOptimo by following up its multi-million-dollar investment with the finalisation of a Strategic Collaboration Agreement and Distribution Framework Agreement.

Clinical trials get the green light

Human trials of a microwearable sensor for the detection of dangerous dehydration levels are set to begin after the latest successful fundraising round for HealthTech firm WearOptimo. The $5 million boost will enable the company to progress its game-changing hydration monitor, through clinical trials at QUT.